Eurofins Scientific

ERFFrance

8 filed reports · 9 financial concepts · 15 earnings calls

Latest figures

Group totals as stated in the company’s own filed reports, each with a link to its report. The change is against the same period a year earlier.

Latest fiscal year

Revenue

—

Latest quarter

Revenue

€1.79B

Q1 FY2026 · to Mar 31, 2026

up +1.2% vs €1.77B

Q1 report

Filed reports

8 reports · Mar 2021 to Mar 2026

Each report counts once it has at least one extracted financial fact.

Report typeReportsFactsPeriods
Q1AMF637Mar 2021 to Mar 2026
Q3AMF224Sep 2022 to Sep 2025

Documents

PeriodTypePeriod endPublishedFactsSource
FY2026 Q1q12026-03-312026-04-228Open
FY2025 Q3q32025-09-302025-10-2118Open
FY2025 Q1q12025-03-312025-04-2311Open
FY2024 Q1q12024-03-312024-04-246Open
FY2023 Q1q12023-03-312023-04-263Open
FY2022 Q3q32022-09-302022-10-186Open
FY2022 Q1q12022-03-312022-04-215Open
FY2021 Q1q12021-03-312021-04-284Open

Financial data

9 concepts · 61 facts

Each concept is one reported line item or metric. The count is how many values of it are held, across the periods shown.

Segment1 concept · 46 facts · Mar 2021 to Mar 2026

  • Revenue46 · Mar 2021 to Mar 2026

KPI5 concepts · 7 facts · Mar 2024 to Sep 2025

  • blood collection points2 · Mar 2024 to Mar 2025
  • new start-up laboratories2 · Mar 2024 to Mar 2025
  • Blood collection points opened1 · Sep 2025
  • Business combinations1 · Mar 2025
  • Total1 · Sep 2025

IFRS1 concept · 6 facts · Mar 2021 to Mar 2026

  • Revenue6 · Mar 2021 to Mar 2026

APM2 concepts · 2 facts · Mar 2022

  • Q1 2022 organic growth rate (b/a-1)1 · Mar 2022
  • Q1 2022 organic scope* revenues (at Q1 2022 FX rates) (b)1 · Mar 2022

Segments

46 facts

Figures broken down by business line, region, product or another axis the company reports on.

Operating segment: europe1 member · 10 facts

  • Europe10 · Mar 2021 to Mar 2026

Operating segment: north america1 member · 10 facts

  • North America10 · Mar 2021 to Mar 2026

Operating segment: rest of the world1 member · 10 facts

  • Rest of the World10 · Mar 2021 to Mar 2026

Area of activity: bio pharma1 member · 4 facts

  • BioPharma4 · Mar 2025 to Mar 2026

Area of activity: consumer & technology products testing1 member · 4 facts

  • Consumer & Technology Products Testing4 · Mar 2025 to Mar 2026

Area of activity: diagnostic services & products1 member · 4 facts

  • Diagnostic Services & Products4 · Mar 2025 to Mar 2026

Area of activity: life1 member · 4 facts

  • Life4 · Mar 2025 to Mar 2026

Text from filings

Management commentary and risk factors, extracted from SEC filings only.

No commentary or risk-factor text for this company.

Earnings calls

15 calls · Aug 2019 to Jul 2026

Transcripts with management claims and analyst questions, one per fiscal period.

  • FY2026 Q22026-07-23
  • FY2026 Q12026-04-22
  • FY2025 Q42026-01-29
  • FY2025 Q32025-10-21
  • FY2025 Q22025-07-23
  • FY2025 Q12025-04-23
  • FY2024 Q42025-01-30
  • FY2024 Q32024-10-22
  • FY2024 Q22024-07-24
  • FY2024 Q12024-04-24
  • FY2023 Q42024-02-27
  • FY2023 Q32023-10-24
  • FY2023 Q12023-04-26
  • FY2022 Q42023-03-03
  • FY2019 Q22019-08-29

Executive media

Podcasts, interviews and conference appearances by the company's executives, with their claims.

No media appearances for this company.

Ask about this company in your AI model

Connect FactIQ to Claude, ChatGPT or another AI model (how to install), then paste this prompt.

Use FactIQ to get the revenue, net income and operating income of Eurofins Scientific (ERF) from its filed reports, for the last five fiscal years and the latest quarter or half year. Link each figure to its filing, and chart the trend.

Works once FactIQ is connected

Reports are counted as filed reports with at least one served fact. Counts are read from the database (last read Nov 20, 2026) and refreshed every few hours.

Eurofins Scientific (ERF): Q1 FY2026 revenue €1.79B · FactIQ